0001650840-20-000002.txt : 20200617 0001650840-20-000002.hdr.sgml : 20200617 20200617141215 ACCESSION NUMBER: 0001650840-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200617 DATE AS OF CHANGE: 20200617 EFFECTIVENESS DATE: 20200617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aerami Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001650840 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-369147 FILM NUMBER: 20969232 BUSINESS ADDRESS: STREET 1: 2520 MERIDIAN PARKWAY STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 9195897495 MAIL ADDRESS: STREET 1: 2520 MERIDIAN PARKWAY STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Dance Biopharm Holdings, Inc. DATE OF NAME CHANGE: 20150819 FORMER COMPANY: FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc. DATE OF NAME CHANGE: 20150812 D 1 primary_doc.xml X0708 D LIVE 0001650840 Aerami Therapeutics Holdings, Inc. 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 9195897495 DELAWARE Dance Biopharm Holdings, Inc. Dance BioPharm Holdings, Inc. Corporation true ANNE C. WHITAKER 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Executive Officer Director JOHN S. PATTON 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director STEVE THORNTON 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director ADAM STERN 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director BENJAMIN WOLIN 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director Mr. Wolin resigned from the Board of Directors effective June 8, 2020. BILL WELCH 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director KENNETH B. LEE, JR. 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director MICHAEL J. KASETA 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Executive Officer TIMM CROWDER 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Executive Officer Other Health Care Decline to Disclose 06b false 2020-06-05 false true false 0 AEGIS CAPITAL CORP. 15007 None None 810 7th AVENUE 22nd FLOOR NEW YORK NY NEW YORK 10019 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS IN INDIANA IA IOWA MA MASSACHUSETTS NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA PA PENNSYLVANIA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WI WISCONSIN false 15000000 4608000 10392000 false 61 1392000 true 0 Estimate based on maximum offering amount of $15,000,000. Warrants to purchase up to 10% of the number of shares sold in the offering will be issued to Placement Agent for nominal consideration. 0 Proceeds to be used for working capital and genl corporate purposes, incl officer and employee salaries & director fees. A portion of proceeds to be used to compensate Placement Agent. Adam Stern, a director of issuer, is an affiliate of Placement Agent. false Aerami Therapeutics Holdings, Inc. /s/ Michael J. Kaseta Michael J. Kaseta Chief Financial Officer 2020-06-17